Brought to you by:
Terumo announces commercial availability of Roadsaver carotid stent system
Terumo Interventional Systems has announced the early commercial availability of its US Food and Drug Administration (FDA)-approved Roadsaver carotid stent system. Indicated for use with Terumo’s Nanoparasol embolic protection system, Roadsaver is intended to treat carotid artery stenosis in patients…
The top 10 most popular Vascular Specialist stories of October 2022
The most-read Vascular Specialist stories in October covered an investigation of thoracic endovascular aortic repair (TEVAR) timing presented at the Eastern Vascular Society (EVS) meeting in Philadelphia (Sept. 29–Oct. 1); the editor-in-chief’s open letter to the National Rifle Association; tips on…
Terumo Aortic announces FDA approval for Thoraflex Hybrid frozen elephant trunk device
Terumo Aortic today announced that the Food and Drug Administration (FDA) has granted approval of the Thoraflex Hybrid frozen elephant trunk device for commercial sale in the U.S. for the treatment of patients with complex aortic arch disease. Thoraflex Hybrid…
RelayPro thoracic stent graft approved by FDA
Terumo Aortic today (Friday, Aug. 6) announced that the Food and Drug Administration (FDA) has granted approval of the RelayPro thoracic stent-graft system for sale in the United States for the treatment of patients with thoracic aortic aneurysms (TAAs) and…
Treo IDE primary endpoint results announced
In the wake of approval by the Food and Drug Administration (FDA) of the Treo abdominal aortic stent-graft system for the treatment of patients with abdominal aortic aneurysms (AAAs), Terumo Aortic has announced the publication of the primary endpoint results…
French study: Third-gen Anaconda endograft indicates satisfactory five-year exclusion
The third-generation Anaconda endograft from Terumo Aortic provides “high technical success” as well as “satisfactory” five-year aneurysm exclusion and clinical success rates, a French multicenter prospective observational study has found. The investigators note that longer-term results with new generation endografts are “essential” due to a…
Terumo Aortic gains FDA approval for Treo endovascular device
Terumo Aortic has been granted Food and Drug Administration (FDA) approval for the Treo abdominal aortic stent-graft system to be sold in the U.S. The Treo, used in the treatment of patients with abdominal aortic aneurysms (AAA), is the only…